Abstract:The abnormal vascular in tumor promotes tumor cells proliferation and metastasis. Endothelial cell (EC), which is usually dysfunctional in tumor microenvironment, affects angiogenesis and vascular function. Neurogenic locus notch homolog protein 1 (NOTCH1) signaling pathway plays a critical role in vascular endothelial growth factor (VEGF) signaling and angiogenesis by driving its intracellular domain (N1ICD) to nucleus and activates downstream signaling. However, regulatory mechanism of N1ICD remains unclear. Small ubiquitin-like modifier (SUMO) proteins express widely and regulate gene expression, stability, and signal transduction via protein post-translational modification. Our previous study has confirmed that N1ICD could be SUMOylated. In the current study, we first found that SUMOylated N1ICD in ECs negatively regulated angiogenic signaling by enhancing the activity and protein stability of N1ICD. To reveal the role of SUMOylated NICD in tumor angiogenesis, we generated inducible endothelial SUMO1-N1ICD knock-in (SUMO1-N1ICDecKI) mice. Xenograft tumor was produced by subcutaneous injection of mice Lewis Lung Cancer cells on the back and analyzed by volume measurement. SUMO1-N1ICDecKI mice developed smaller tumor than WT mice at 14 days after injection. Immunofluorescence (IF) staining of EC marker also indicated that vessel density of tumors in SUMO1-N1ICDecKI mice was much lower than tumors in WT mice. To further explore the mechanism, VEGFR2 and p-VEGFR2 was measured by IF staining. Increased levels of endothelial-specific N1ICD SUMOylation correlated with lower VEGFR2 expression and p-VEGFR2 signal. On the other hand, we also detected platelet-derived growth factor β (PDGFRβ) to measure vascular integrity. Surprisingly, vessels with enhanced N1ICD SUMOylation associated with more PDFGFβ+ pericyte coverage, indicating that endothelial N1ICD SUMOylation promotes vessel stability. Taken together, we conclude that endothelial-specific N1ICD SUMOylation suppressed tumor growth and tumor angiogenesis while protected vascular integrity.

SUMOylation is Required for PIPK1γ‐driven Keratinocyte Migration and Growth

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

SUMOylation mediates the disassembly of the Smad4 nuclear export complex via RanGAP1 in KELOIDS

SUMO‐specific Protease 2 (SENP2) Suppresses Keratinocyte Migration by Targeting NDR1 for De‐sumoylation

SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function.

Abstract 4294: SUMOylation Promotes Nuclear Import and Stabilization of Polo-Like Kinase 1 to Support Its Mitotic Function

SUMOylation of RhoGDIα is Required for Its Repression of Cyclin D1 Expression and Anchorage-Independent Growth of Cancer Cells

Regulation of cytokine-independent survival kinase (CISK) by the Phox homology domain and phosphoinositides

Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells

Phosphoprotein Phosphatase 1 is Required for Extracellular Calcium-Induced Keratinocyte Differentiation

Data from Akt SUMOylation Regulates Cell Proliferation and Tumorigenesis

The Interplay Between SUMOylation and Phosphorylation of PKCδ Facilitates Oxidative Stress‐induced Apoptosis

SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses*

SUMOylation mediates CtIP’s functions in DNA end resection and replication fork protection

Stepwise phosphorylation and SUMOylation of PIDD1 drive PIDDosome assembly in response to DNA repair failure

SUMOylation Regulates the Localization and Activity of Polo-like Kinase 1 During Cell Cycle in the Silkworm, Bombyx Mori

PIP5KI Gamma is Required for Cardiovascular and Neuronal Development.

PDPK1 regulates autophagosome biogenesis by binding to PIK3C3